Neurokinin B Stimulates Reproductive Organ Growth in Male Rats

Neurokinin B increased seminal vesicle weight, tissue height, and fructose secretion in rats in a dose-dependent manner through NK3 receptors.

Ramzan, Muhammad Haris et al.·Current protein & peptide science·2024·Preliminary Evidenceanimal study
RPEP-09118Animal studyPreliminary Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
animal study
Evidence
Preliminary Evidence
Sample
N=60
Participants
Adult male Sprague Dawley rats (n=10 per group, 6 groups) receiving neurokinin B, agonist, or antagonist

What This Study Found

Neurokinin B at three doses (1 μg, 1 ng, and 10 pg) administered intraperitoneally for 12 days increased seminal vesicle weight, epithelial height, and seminal fructose levels in a dose-dependent manner. Senktide (an NK3R agonist) produced similar effects. SB222200 (an NK3R antagonist) slightly decreased these parameters.

Light microscopy showed increased epithelial height and folding in all neurokinin B and senktide groups. Immunohistochemistry for NK3 receptor expression showed no change with treatment, suggesting the receptor is constitutively expressed.

Critically, all effects reversed when rats were kept for 12 days without treatment, indicating the changes are stimulatory and reversible rather than permanent.

Key Numbers

  • 10 rats per group (6 groups)
  • Treatment: 12 days intraperitoneal
  • Reversal period: 12 days without treatment
  • Neurokinin B doses: 1 μg, 1 ng, 10 pg
  • Senktide (agonist): 1 μg
  • SB222200 (antagonist): 1 μg
  • Increased: seminal vesicle weight, epithelial height, seminal fructose
  • NK3R expression: unchanged
  • All effects reversed after treatment cessation

How They Did This

Adult male Sprague Dawley rats (n=10 per group) received 12 days of intraperitoneal injections: neurokinin B at 1 μg, 1 ng, or 10 pg; senktide (NK3R agonist) at 1 μg; or SB222200 (NK3R antagonist) at 1 μg. Half were sacrificed after treatment, half kept for 12 more days without treatment (reversal period). Seminal vesicles were analyzed by light microscopy, immunohistochemistry, and seminal fructose measurement.

Why This Research Matters

Neurokinin B is known to stimulate reproductive hormones through GnRH (gonadotropin-releasing hormone). But its direct effects on reproductive organs like seminal vesicles were unknown. This study shows neurokinin B has a stimulatory effect on seminal vesicle growth and function, which could be relevant for understanding male fertility and potentially for fertility treatments.

The Bigger Picture

Neurokinin B is known to regulate reproductive hormones through GnRH. This study shows it also has direct effects on reproductive organs, expanding understanding of its role in male fertility.

What This Study Doesn't Tell Us

This was tested in rats, not people. The intraperitoneal injection route delivers peptide systemically, which differs from natural neurokinin B release patterns. The dose range spans a million-fold (1 μg to 10 pg), making dose-response interpretation complex. The study measured structural and biochemical changes but not actual fertility or sperm quality. NK3R expression did not change, which limits mechanistic interpretation.

Questions This Raises

  • ?Could neurokinin B pathway manipulation treat male infertility?
  • ?Do these effects translate to humans?

Trust & Context

Key Stat:
Fully reversible effects All neurokinin B effects on seminal vesicles reversed completely within 12 days of stopping treatment
Evidence Grade:
Rated preliminary: well-designed animal pharmacology study with mechanism confirmation, but entirely in rats with no human data.
Study Age:
Published in 2024. Contributes to the growing understanding of neurokinin B's role in reproductive physiology.
Original Title:
Neurokinin B Administration Induces Dose Dependent Proliferation of Seminal Vesicles in Adult Rats.
Published In:
Current protein & peptide science, 25(4), 339-352 (2024)
Database ID:
RPEP-09118

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What is neurokinin B?

A 10-amino-acid peptide involved in reproductive hormone regulation. It signals through GnRH to control reproductive function.

Could this lead to fertility treatments?

Potentially. Understanding neurokinin B's effects on reproductive organs could inform new approaches to male infertility, but this is early animal research.

Read More on RethinkPeptides

Cite This Study

RPEP-09118·https://rethinkpeptides.com/research/RPEP-09118

APA

Ramzan, Muhammad Haris; Shah, Mohsin; Ramzan, Faiqah. (2024). Neurokinin B Administration Induces Dose Dependent Proliferation of Seminal Vesicles in Adult Rats.. Current protein & peptide science, 25(4), 339-352. https://doi.org/10.2174/0113892037264538231128072614

MLA

Ramzan, Muhammad Haris, et al. "Neurokinin B Administration Induces Dose Dependent Proliferation of Seminal Vesicles in Adult Rats.." Current protein & peptide science, 2024. https://doi.org/10.2174/0113892037264538231128072614

RethinkPeptides

RethinkPeptides Research Database. "Neurokinin B Administration Induces Dose Dependent Prolifera..." RPEP-09118. Retrieved from https://rethinkpeptides.com/research/ramzan-2024-neurokinin-b-administration-induces

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.